The debate breaks down like this: PBMs negotiate rebates with the   different drugmakers. The terms of these   rebate contracts are variable and secret. The more lives a   PBM covers, the more leverage it tends to have in negotiating   steeper rebates, which is why some PBMs may walk away with   rebates twice as big as those of their competitors. â€™ "    